Israeli immunotherapeutic developer Nasvax has announced that it has raised $1 million. The sum was raised from Chinese firm Acebright, which develops cancer and infectious disease treatments.
Acebright’s investment will give it 10 percent ownership of the Israeli company. The Chinese company also said that it might participate in further financing rounds held by Nasvax.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

US Soldiers, Vets To Get Israeli-Made Helmets To Treat Depression
September 27, 2023

Israeli Startups Raise $1.6B in Q3, Indicating Stabilization - Report
September 27, 2023

Global Chip Maker Buying Renewable Energy From Israeli Firm
September 27, 2023

VC Fund Raises $480M For Cybersecurity Investment
September 26, 2023
Facebook comments